Resistance Training in Elderly

This study has been completed.
Sponsor:
Collaborators:
The Anna Foundation
DSM Food Specialties
Information provided by:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT00744094
First received: August 28, 2008
Last updated: NA
Last verified: August 2008
History: No changes posted
  Purpose

In the present study the investigators aim to determine whether protein supplementation can augment the response to a 12 week resistance training program in healthy elderly men.


Condition Intervention Phase
Sarcopenia
Atrophy
Aging
Dietary Supplement: protein drink
Behavioral: Resistance training
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Influence of Resistance Training on Body Composition and Muscle Characteristics in Healthy Elderly

Further study details as provided by Maastricht University Medical Center:

Primary Outcome Measures:
  • Muscle mass measured at limb and cellular level [ Time Frame: before and after 12 weeks of intervention ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Muscle strength [ Time Frame: before and after 12 weeks of intervention ] [ Designated as safety issue: No ]
  • Body composition [ Time Frame: before and after 12 weeks of intervention ] [ Designated as safety issue: No ]

Enrollment: 26
Study Start Date: January 2007
Study Completion Date: July 2008
Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: 1
placebo drink
Behavioral: Resistance training
12 weeks resistance training, 3 days per week
Experimental: 2
protein drink
Dietary Supplement: protein drink
250 ml protein hydrolysate solution
Behavioral: Resistance training
12 weeks resistance training, 3 days per week

  Eligibility

Ages Eligible for Study:   65 Years to 85 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Living independently

Exclusion Criteria:

  • Diabetes
  • Cardiovascular disease
  • Orthopedic limitations
  • Any disorder known to compromise ability for resistance training
  • History of resistance training in past 5 years
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00744094

Locations
Netherlands
Maastricht University
Maastricht, Netherlands, 6200MD
Sponsors and Collaborators
Maastricht University
The Anna Foundation
DSM Food Specialties
Investigators
Principal Investigator: Luc JC van Loon, PhD Maastricht University
  More Information

No publications provided by Maastricht University Medical Center

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Dr. L. van Loon, Maastricht University
ClinicalTrials.gov Identifier: NCT00744094     History of Changes
Other Study ID Numbers: MEC 06-3-062B
Study First Received: August 28, 2008
Last Updated: August 28, 2008
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by Maastricht University Medical Center:
resistance training
protein supplementation
hypertrophy

Additional relevant MeSH terms:
Atrophy
Sarcopenia
Pathological Conditions, Anatomical
Muscular Atrophy
Neuromuscular Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on April 16, 2014